Thanks @shax786 - I would defer to the more scientific posters like @otherperspective and @LeftYahoo on their opinions
There are risks, but I'd look at the following to gain a level of confidence:...
- We did not make a new product, specifically for Covid-19. We've been working on Rem-L for a long time, it just happens that it also works well for Covid-19 ARDS
- SI & team - would not risk damaging Mesoblast suite of products at the 11th hour to pivot for ARDS, if he didn't have sufficient data
- Rem-L is safe and effective; as demonstrated in ODAC and Japan
- EAP success
- NIH willing to back Mesoblast (to the tune of US$50m or so)
- All these hospitals signing up
- The doctors, who have been interviewed have nothing but praises
However, there are two main risks for me with Covid-19 ARDS:
- 90 patients is not enough patients for DSMB to call off the trial due to overwhelming success. My concern here is not the % of success, but rather the 45 patients being treated on Rem-L is not enough. But, hey these are legit numbers that the FDA as agreed to - so who knows
- Manufacturing - Mesoblast has been dealing with a niche market for aGVHD and are not ready for the massive massive lift in volume to deal with Covid-19 ARDS. The last CR was specifically raised to deal with this, but it all takes time. If the FDA had concerns with manufacturing for a niche aGVHD market, what concerns would they have with Covid-19 ARDS. So, with pressure from the WH some manufacturing news/ partnership is required here - FDA themselves need to step up and allow an accelerated path for 3D
- Forums
- ASX - By Stock
- MSB
- MSB - Most exciting 6 months
MSB - Most exciting 6 months, page-619
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 32922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | 1.385 |
5 | 70251 | 1.380 |
15 | 100605 | 1.375 |
8 | 96825 | 1.370 |
3 | 43018 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 32922 | 2 |
1.400 | 77386 | 10 |
1.405 | 24018 | 1 |
1.410 | 116617 | 7 |
1.415 | 58649 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online